eli lilly oral tirzepatide FDA approves Lilly's for weight loss FDA Approves Lilly's Zepbound for

these are areas of investigation, not guaranteed outcomes

Menopausal women are three times more likely to develop obesity and metabolic syndrome compared to their premenopausal counterparts

Magosso E, Ansari MA, Gopalan Y, et al

Includes a unique botanical support blend to promote detox and antioxidant synergy*

Sermorelin May Be Better If You: Are primarily focused on long-term anti-aging and wellness Want to reinforce natural hormone signaling patterns Prioritize sleep quality improvement Prefer a peptide with prior FDA-approved status Are looking for gradual, sustainable improvements Ipamorelin May Be Better If You: Have specific fat loss or body recomposition goals Are sensitive to hormonal side effects Prioritize workout recovery and physical performance Have experienced side effects with other peptides or GH secretagogues Want a targeted, clean GH-stimulation approach Combination Therapy May Be Best If You: Want comprehensive GH optimization through dual-pathway synergy Are seeking the most robust clinical response Have been evaluated by a physician and cleared for combination use Want to address multiple symptoms simultaneously (sleep, recovery, body composition) Safety, Side Effects, and Medical Oversight Both peptides are generally well tolerated under proper medical supervision, but they are not one-size-fits-all treatments